Planejamento de inibidores baseado em fragmentos moleculares para a enzima gliceraldeído-3-fosfato desidrogenase de Trypanosoma cruzi / Design of inhibitors through fragment-based drug discovery for the enzyme glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma cruzi
AUTOR(ES)
Geraldo Rodrigues Sartori
FONTE
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia
DATA DE PUBLICAÇÃO
20/04/2012
RESUMO
Chagas disease is a parasitic illness endemic in Latin America caused by the trypanosomatid parasite Trypanosoma cruzi that spreads around the world due to people migration. Nowadays, Benznidazole and Nifurtimox (banned in Brazil), are used for the treatment of this disease but causes severe side effects to patients. Recently, three new molecules have reached clínical trials phase in the development of drugs against Chagas disease but it is still necessary to develop new drugs. In this studies, the enzyme Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) was used as a target for the search of new antitrypanosomatid molecules. It belongs to the glycolytic pathway, the major one for parasite\ s energy generation. With the aim searching a new molecule that inhibits this enzyme, the fragment-based approach guided the search of molecules with high ligand efficiency. A focused compound library was assembled from a database of 500,000 molecules using molecular and solubility filters and the Rule of Three. The integrated use of ligand (chemical and electrostatic similarity) and target (molecular docking) based drug design was carried out to rank the molecular fragments by a consensual score. Through visual inspection of the top 500 molecules five diverse fragments were selected for the in vitro enzymatic assays using fluorescence spectroscopy. One of these molecules shows a Ki equals to (425 ± 53) μM and ligand efficiency equals to 0,33, a promising value for the fragment-based approach. Additionally, Molecular Dynamics simulations (MD) were carried out with these fragments and the predicted energy of interaction for fragment-enzyme complex was able to rank the molecules as using the experimental results. Furthermore, the MD was useful to predict the mode of interaction of the fragments in the active site of enzyme and to reveal a new cavity close to the substrate binding site. A second generation of compounds was selected based on the structure of the active fragment to construct theoretical structure-activity relationship (SAR) using MD. SAR indicates that the presence of a nitrogen with hydrogen-bond donor property is important to the interaction, making hydrogen-bonding with the amino acid residue Asp210. In addition, MD shows the influence of different substituent posítion in the central ring in the energy of the interaction, with a 2,3 substitution at five-atom ring the most favorable. This study identifies the first molecular fragment with high ligand efficiency for the enzyme TcGAPDH, with the combined use of ligand and target-based tools and fluorescence spectroscopy, for selection and identification of active compounds against the enzyme. MD was able to reproduce experimental results and generate theoretical information of SAR to the active molecular fragment.
ASSUNTO(S)
dinâmica molecular fragment-based drug design molecular dynamics simulation planejamento baseado em fragmentos tcgapdh tcgapdh
Documentos Relacionados
- Planejamento de inibidores da enzima gliceraldeído-3-fosfato desidrogenase de Trypanosoma cruzi por biocalorimetria
- Inhibitor design for glyceraldehyde-3-phosphate dehydrogenase enzyme from Trypanosoma cruzi: structural biology and medicinal chemistry
- Otimização do flavonoide tilirosídeo como inibidor da enzima gliceraldeído-3-fosfato desidrogenase de Trypanosoma cruzi
- Rational design of new chemotherapeutic agents: identification and kinetic studies of new inhibitors of glycosomal glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma cruzi
- Busca de inibidores da enzima glicossomal gliceraldeído 3-fosfato desidrogenase de Trypanosoma cruzi